Clinical Risk Factor for Detected Distant Metastasis and Anaplastic Transformation After Reoperation in Recurrent/Persistent Differentiated Thyroid Cancer: A Retrospective Cohort Study

复发/持续性分化型甲状腺癌再次手术后远处转移和间变性转化的临床危险因素:一项回顾性队列研究

阅读:2

Abstract

OBJECTIVES: Research on detected distant metastasis or anaplastic transformation in recurrent/persistent differentiated thyroid cancer is limited. We analyzed the clinical factors associated with detected distant metastasis or anaplastic transformation following reoperation for differentiated thyroid cancer. METHODS: This retrospective review included 336 patients who underwent reoperation for differentiated thyroid cancer with detection of distant metastasis or anaplastic transformation following reoperation. The hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated. RESULTS: Distant metastasis was detected in 45 patients (45/336, 13.4%) after reoperation. The risk of distant metastasis was higher for patients of male sex (adjusted HR: 2.373; 95% CI: 1.133-4.973), age ≥ 55 (adjusted HR: 4.991; 95% CI: 2.451-10.165), initial T3-4 stage (adjusted HR: 2.347; 95% CI: 1.035-5.321), in-field recurrence (adjusted HR: 3.267; 95% CI: 1.489-7.168), and those who had undergone ≥ 3 reoperations (adjusted HR: 3.378; 95% CI: 1.248-9.174). Anaplastic transformation was detected in 7 patients (7/336, 2.1%) after reoperation. The risk of anaplastic transformation was higher for patients with an age ≥ 55 (adjusted HR: 6.811; 95% CI: 1.300-35.676) and those who had undergone ≥ 3 reoperations (adjusted HR: 5.672; 95% CI: 1.139-28.236). CONCLUSION: In recurrent/persistent differentiated thyroid cancer, distant metastasis or anaplastic transformation following reoperation is not insignificant. There may be increased risk of distant metastasis or anaplastic transformation with multiple reoperations in patients who are men, aged ≥ 55, or at the initial T3-T4 stage. LEVEL OF EVIDENCE: 4.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。